Publicaciones en colaboración con investigadores/as de St George's, University of London (28)

2023

  1. Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study

    The Lancet Global Health, Vol. 11, Núm. 2, pp. e218-e228

  2. Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study

    Clinical and Experimental Allergy, Vol. 53, Núm. 3, pp. 337-352

2022

  1. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study

    European Respiratory Journal, Vol. 60, Núm. 3

  2. The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study

    European Respiratory Journal, Vol. 60, Núm. 3

  3. Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I

    Pediatric Allergy and Immunology, Vol. 33, Núm. 1

2021

  1. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

    The Lancet, Vol. 398, Núm. 10311, pp. 1569-1580

2020

  1. Comparison of individual-level and population-level risk factors for rhinoconjunctivitis, asthma, and eczema in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three

    World Allergy Organization Journal, Vol. 13, Núm. 6

  2. Global asthma network phase i surveillance: geographical coverage and response rates

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-17

  3. Trends in worldwide asthma prevalence

    European Respiratory Journal, Vol. 56, Núm. 6

2019

  1. Are Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation?

    Journal of Investigative Dermatology, Vol. 139, Núm. 5, pp. 1023-1036

  2. Are environmental risk factors for current wheeze in the international study of asthma and allergies in childhood (ISAAC) phase three due to reverse causation?

    Clinical and Experimental Allergy, Vol. 49, Núm. 4, pp. 430-441

  3. Calling time on asthma deaths in tropical regions—how much longer must people wait for essential medicines?

    The Lancet Respiratory Medicine

2017

  1. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors

    European Respiratory Journal, Vol. 49, Núm. 1

2014

  1. Birthweight and the risk of atopic diseases: The ISAAC Phase III study

    Pediatric Allergy and Immunology, Vol. 25, Núm. 3, pp. 264-270

2013

  1. Asthma in the global NCD agenda: A neglected epidemic

    The Lancet Respiratory Medicine

  2. Asthma phenotypes identified by latent class analysis in the ISAAC phase II Spain study

    Clinical and Experimental Allergy, Vol. 43, Núm. 2, pp. 223-232

2012

  1. Changes over time in the relationship between symptoms of asthma, rhinoconjunctivitis and eczema: A global perspective from the International Study of Asthma and Allergies in Childhood (ISAAC)

    Allergologia et Immunopathologia, Vol. 40, Núm. 5, pp. 267-274

  2. Tuberculosis, bacillus Calmette-Guérin vaccination, and allergic disease: Findings from the International Study of Asthma and Allergies in Childhood Phase Two

    Pediatric Allergy and Immunology, Vol. 23, Núm. 4, pp. 324-331

2011

  1. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International study of asthma and allergies in childhood phase three

    American Journal of Respiratory and Critical Care Medicine, Vol. 183, Núm. 2, pp. 171-178

  2. Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6-7 year old children: ISAAC Phase Three

    Allergologia et Immunopathologia, Vol. 39, Núm. 6, pp. 318-325